PubRank

International journal for parasitology. Drugs and drug resistance (Int J Parasitol Drugs Drug Resist)

Journal PubWeight™ 149.88‹?›

Top papers

Rank Title Year PubWeight™‹?›
51 Anthelmintic resistance to ivermectin and moxidectin in gastrointestinal nematodes of cattle in Europe. 2015 0.85
52 Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya. 2014 0.85
53 Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes. 2014 0.85
54 Evaluation of the growth-inhibitory effect of trifluralin analogues on in vitro cultured Babesia bovis parasites. 2013 0.84
55 Global analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinine. 2012 0.84
56 Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist. 2016 0.84
57 Phenotyping clinical resistance to chloroquine in Plasmodium vivax in northeastern Papua, Indonesia. 2011 0.84
58 Distribution patterns of three sodium channel mutations associated with pyrethroid resistance in Rhipicephalus (Boophilus) microplus populations from North and South America, South Africa and Australia. 2012 0.84
59 A novel marker, ARM58, confers antimony resistance to Leishmania spp. 2013 0.84
60 Polymorphism in ion channel genes of Dirofilaria immitis: Relevant knowledge for future anthelmintic drug design. 2016 0.83
61 Effects of the green tea catechin (-)-epigallocatechin gallate on Trypanosoma brucei. 2012 0.83
62 In silico analysis of the binding of anthelmintics to Caenorhabditis elegansP-glycoprotein 1. 2016 0.83
63 Exploring the mode of action of ebselen in Trypanosoma brucei hexokinase inhibition. 2013 0.83
64 Relative level of thiabendazole resistance associated with the E198A and F200Y SNPs in larvae of a multi-drug resistant isolate of Haemonchus contortus. 2012 0.83
65 Antimony resistance and environment: Elusive links to explore during Leishmania life cycle. 2012 0.83
66 Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice. 2015 0.83
67 Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present. 2012 0.83
68 Target-based vs. phenotypic screenings in Leishmania drug discovery: A marriage of convenience or a dialogue of the deaf? 2014 0.82
69 Profiling the macrofilaricidal effects of flubendazole on adult female Brugia malayi using RNAseq. 2016 0.82
70 Microfluidic platform for electrophysiological recordings from host-stage hookworm and Ascaris suum larvae: A new tool for anthelmintic research. 2016 0.82
71 Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites. 2015 0.82
72 TRP channels in schistosomes. 2016 0.82
73 microRNAs of parasitic helminths - Identification, characterization and potential as drug targets. 2014 0.82
74 Oxadiazole 2-oxides are toxic to the human hookworm, Ancylostoma ceylanicum, however glutathione reductase is not the primary target. 2012 0.82
75 Trypanosoma brucei adenine-phosphoribosyltransferases mediate adenine salvage and aminopurinol susceptibility but not adenine toxicity. 2013 0.82
76 A single mutation in the gatekeeper residue in TgMAPKL-1 restores the inhibitory effect of a bumped kinase inhibitor on the cell cycle. 2014 0.82
77 Functional expression and characterization of the C. elegans G-protein-coupled FLP-2 Receptor (T19F4.1) in mammalian cells and yeast. 2012 0.82
78 Identification of β-hematin inhibitors in the MMV Malaria Box. 2015 0.81
79 Recent highlights in anti-protozoan drug development and resistance research. 2012 0.81
80 Trypanocidal action of bisphosphonium salts through a mitochondrial target in bloodstream form Trypanosoma brucei. 2015 0.81
81 Screening of the 'Pathogen Box' identifies an approved pesticide with major anthelmintic activity against the barber's pole worm. 2016 0.81
82 Identification of plumbagin and sanguinarine as effective chemotherapeutic agents for treatment of schistosomiasis. 2013 0.81
83 High level expression of a glutamate-gated chloride channel gene in reproductive tissues of Brugia malayi may explain the sterilizing effect of ivermectin on filarial worms. 2014 0.81
84 Limited efficacy of pour-on anthelmintic treatment of cattle under Swedish field conditions. 2013 0.81
85 Inhibitors of RNA editing as potential chemotherapeutics against trypanosomatid pathogens. 2011 0.81
86 Chemotherapeutics challenges in developing effective treatments for the endemic malarias. 2012 0.81
87 In silico prediction of antimalarial drug target candidates. 2012 0.80
88 Quantitative assessment of the proliferation of the protozoan parasite Perkinsus marinus using a bioluminescence assay for ATP content. 2013 0.80
89 Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery. 2014 0.80
90 A reappraisal of the relative sensitivity of nematode pharyngeal and somatic musculature to macrocyclic lactone drugs. 2011 0.80
91 The in vitro assay profile of macrocyclic lactone resistance in three species of sheep trichostrongyloids. 2013 0.80
92 Development of an in vitro bioassay for measuring susceptibility to macrocyclic lactone anthelmintics in Dirofilaria immitis. 2013 0.80
93 Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya. 2015 0.80
94 Viability of developmental stages of Schistosoma mansoni quantified with xCELLigence worm real-time motility assay (xWORM). 2015 0.80
95 A comparative study of the effects of four treatment regimes on ivermectin efficacy, body weight and pasture contamination in lambs naturally infected with gastrointestinal nematodes in Scotland. 2013 0.80
96 WIPO Re:Search: Accelerating anthelmintic development through cross-sector partnerships. 2014 0.80
97 Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development. 2015 0.80
98 Duplex quantitative Reverse-Transcriptase PCR for simultaneous assessment of drug activity against Leishmania intracellular amastigotes and their host cells. 2013 0.80
99 In vitro and in vivo assessment of the effect of antiprotozoal compounds isolated from Psoralea corylifolia against Ichthyophthirius multifiliis in fish. 2015 0.79
100 Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target. 2016 0.79
Next 50